Jennifer Sanfilippo
Responsabile della Conformità presso MELINTA THERAPEUTICS, INC.
Profilo
Jennifer A.
Sanfilippo is currently the Chief Executive Officer at Rempex Pharmaceuticals, Inc. and the Chief Compliance Officer & General Counsel at Melinta Therapeutics, Inc. Previously, she worked as an Attorney at Porzio, Bromberg & Newman PC.
She completed her undergraduate degree at New York University and her graduate degree at Rutgers Law School.
Posizioni attive di Jennifer Sanfilippo
Società | Posizione | Inizio |
---|---|---|
MELINTA THERAPEUTICS, INC. | Responsabile della Conformità | - |
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Amministratore Delegato | - |
Precedenti posizioni note di Jennifer Sanfilippo
Società | Posizione | Fine |
---|---|---|
Porzio, Bromberg & Newman PC
Porzio, Bromberg & Newman PC Miscellaneous Commercial ServicesCommercial Services Porzio, Bromberg & Newman PC provides legal services. Its practice area include bankruptcy, data privacy and cyber security, FDA, litigation, real estate and intellectual property. The company was founded in 1962 and is headquartered in Morristown, NJ. | Corporate Officer/Principal | - |
Formazione di Jennifer Sanfilippo
New York University | Undergraduate Degree |
Rutgers Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
Porzio, Bromberg & Newman PC
Porzio, Bromberg & Newman PC Miscellaneous Commercial ServicesCommercial Services Porzio, Bromberg & Newman PC provides legal services. Its practice area include bankruptcy, data privacy and cyber security, FDA, litigation, real estate and intellectual property. The company was founded in 1962 and is headquartered in Morristown, NJ. | Commercial Services |
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Jennifer Sanfilippo